US Patent 10668074 Uses of DPP IV inhibitors
Patent 10668074 was granted and assigned to Boehringer Ingelheim on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 14, 2018
Date of Patent
June 2, 2020
Patent Applicant
Patent Application Number
16103096
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10668074 Uses of DPP IV inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.